Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scheduled intravenous acetaminophen after head and neck tumor surgery
jRCT1041230004Completed
- Sponsor
- Grants-in-Aid for Scientific Research
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of acetaminophen in head and neck cancer (HNC), sponsored by Grants-in-Aid for Scientific Research. Primary endpoint: Pain visual analog scale score. Started Apr 2023; status: completed.
02
Drugs
acetaminophen
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on jRCT1041230004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041230004.